We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-3.39%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.61B
AUM Growth
-$361M
Cap. Flow
-$253M
Cap. Flow %
-15.72%
Top 10 Hldgs %
19.7%
Holding
501
New
10
Increased
104
Reduced
55
Closed
295

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$14.9M
2
PDD icon
Pinduoduo
PDD
+$13.3M
3
CIXX
CI Financial Corp.
CIXX
+$12.5M
4
FATE icon
Fate Therapeutics
FATE
+$9.95M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$8.89M

Top Sells

Rank Stock Value
1
INMD icon
InMode
INMD
+$18.3M
2
QDEL icon
QuidelOrtho
QDEL
+$14.1M
3
HALO icon
Halozyme
HALO
+$13.6M
4
TCOM icon
Trip.com Group
TCOM
+$13M
5
AMZN icon
Amazon
AMZN
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.98%
2 Consumer Discretionary 13.16%
3 Financials 11.73%
4 Technology 5.09%
5 Industrials 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
26
Allogene Therapeutics
ALLO
$714M
$23.5M 1.46%
914,416
+140,854
+18% +$3.34M
ELS icon
27
Equity Lifestyle Properties
ELS
$12.4B
$23.4M 1.46%
300,000
-80,000
-21% -$6.56M
CHE icon
28
Chemed
CHE
$7.07B
$23.3M 1.44%
50,000
– –
ABBV icon
29
AbbVie
ABBV
$440B
$23.2M 1.44%
216,139
-25,000
-10% -$2.86M
TWST icon
30
Twist Bioscience
TWST
$7.85B
$23.2M 1.44%
216,884
+20,208
+10% +$2.31M
MED icon
31
Medifast
MED
$130M
$23.1M 1.44%
120,000
+35,000
+41% +$8.6M
NBIX icon
32
Neurocrine Biosciences
NBIX
$15.9B
$23M 1.43%
239,983
+23,192
+11% +$2.19M
PHM icon
33
Pultegroup
PHM
$24.6B
$21.8M 1.36%
475,734
-765
-0.2% -$39.8K
IOVA icon
34
Iovance Biotherapeutics
IOVA
$3.05B
$21.4M 1.33%
869,540
+80,978
+10% +$1.91M
TXG icon
35
10x Genomics
TXG
$7.52B
$20.8M 1.29%
142,772
+39,858
+39% +$6.84M
NVTA
36
DELISTED
Invitae Corporation
NVTA
$20.6M 1.28%
723,542
+67,405
+10% +$1.98M
LHCG
37
DELISTED
LHC Group LLC
LHCG
$20.4M 1.27%
130,000
-5,000
-4% -$939K
NTLA icon
38
Intellia Therapeutics
NTLA
$1.69B
$20M 1.24%
148,806
-6,395
-4% -$968K
AAPL icon
39
Apple
AAPL
$4.41T
$19.8M 1.23%
150,591
+14,628
+11% +$2.15M
IMGN
40
DELISTED
Immunogen Inc
IMGN
$17.1M 1.06%
3,013,467
+358,629
+14% +$2.07M
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$16.5M 1.02%
93,157
+19,447
+26% +$3.13M
MSFT icon
42
Microsoft
MSFT
$3.66T
$16.3M 1.01%
62,178
+6,372
+11% +$1.85M
BNTX icon
43
BioNTech
BNTX
$23.3B
$16.1M 1%
59,023
-34,816
-37% -$11.1M
INMD icon
44
InMode
INMD
$875M
$15.9M 0.99%
200,000
-300,000
-60% -$18.3M
INDA icon
45
iShares MSCI India ETF
INDA
$6.58B
$15.5M 0.96%
340,600
-10,600
-3% -$494K
MDRX
46
DELISTED
Veradigm Inc. Common Stock
MDRX
$15.2M 0.95%
1,140,475
+143,120
+14% +$2.31M
NBIS
47
Nebius Group N.V.
NBIS
$65.8B
$14.2M 0.88%
184,760
– –
DRNA
48
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$14.1M 0.88%
701,305
+65,294
+10% +$1.8M
AMWL icon
49
American Well
AMWL
$215M
$14M 0.87%
76,651
+18,098
+31% +$3.93M
PDD icon
50
Pinduoduo
PDD
$127B
$13.5M 0.84%
150,940
+136,583
+951% +$13.3M
1
2
3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q3 2021 Portfolio in Review

As of Q3 2021, Lombard Odier Asset Management (Switzerland) held 501 positions worth $1.61B, down 18% from $1.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lombard Odier Asset Management (Switzerland) withdrew a net $253M in Q3 2021, closing 295 positions and reducing 55 holdings. Its most notable exit was QuidelOrtho, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 50% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in Futu Holdings worth $12.1M.

  • Lombard Odier Asset Management (Switzerland)'s largest Q3 2021 buy was Futu Holdings: 135,132 shares worth $12.1M.
  • Lombard Odier Asset Management (Switzerland) added most to Pinduoduo in Q3 2021, an estimated $13.3M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q3 2021 reduction was InMode, cutting an estimated $18.3M.
  • Lombard Odier Asset Management (Switzerland) fully exited QuidelOrtho in Q3 2021, selling an estimated $14.1M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 20% of its $1.61B portfolio in Q3 2021.
  • Lombard Odier Asset Management (Switzerland) opened 10 new positions and closed 295 in Q3 2021.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 18% quarter-over-quarter to $1.61B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2021, filed 12 Nov 2021.